Fresenius Kabi Recalls Subpotent Fluphenazine Decanoate Injection Vials
Fresenius Kabi USA is recalling 118,224 vials of Fluphenazine Decanoate Injection because the drug was found to be subpotent.
- Product
- Fluphenazine Decanoate Injection, USP; 25 mg/mL, 5mL vials, Rx only, APP Pharmaceuticals, LLC Schaumburg, IL 60173, NDC 63323-0272-05
- Category
- Drug
- Distribution
- Distributed nationwide